NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: The Heinz Nixdorf Recall study

International Journal of Cardiology

Volumn 183, Issue , 2015, Pages 155-161

  Kara, Kaffer ^a,b   Lehmann, Nils ^c   Neumann, Till ^b   Kälsch, Hagen ^b   Möhlenkamp, Stefan ^d   Dykun, Iryna ^b   Broecker Preuss, Martina ^c   Pundt, Noreen ^c   Moebus, Susanne ^c   Jöckel, Karl Heinz ^c   Erbel, Raimund ^b   Mahabadi, Amir A ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Krankenhaus Bethanien   (Germany)

Author keywords

BN; Epidemiology; General population; Heinz Nixdorf Recall Study; Natriuretic peptides; PNT proBNP; Risk prediction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENDER; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPARATIVE STUDY; GERMANY; METABOLISM; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84926665114     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.01.082     Document Type: Article

References (27)

1. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
2. K. Kara, A.A. Mahabadi, and M.H. Berg et al. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study Eur. J. Prev. Cardiol. 21 2014 1171 1179
3. T.J. Wang, M.G. Larson, and D. Levy et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death N. Engl. J. Med. 350 2004 655 663
4. K. Kara, A.A. Mahabadi, and M.H. Geisel et al. B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events - the Heinz Nixdorf Recall Study Clin. Res. Cardiol. 103 2014 125 132
5. K. Kara, J. Gronewold, and T. Neumann et al. B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification Eur. J. Neurol. 21 2014 914 921
6. J. Mair Biochemistry of B-type natriuretic peptide - where are we now? Clin. Chem. Lab. Med. 46 2008 1507 1514
7. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur. Heart J. 27 2006 330 337
8. M.A. Nadir, S. Rekhraj, L. Wei, T.K. Lim, J. Davidson, T.M. MacDonald, C.C. Lang, E. Dow, and A.D. Struthers Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease J. Am. Coll. Cardiol. 60 2012 960 968
9. M. Ledwidge, J. Gallagher, and C. Conlon et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial JAMA 310 2013 66 74
10. R. Erbel, S. Möhlenkamp, and S. Moebus et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study J. Am. Coll. Cardiol. 56 2010 1397 1406
11. A. Schmermund, S. Möhlenkamp, and A. Stang et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf Recall Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle Am. Heart J. 144 2002 212 218
12. A.A. Mahabadi, N. Lehmann, and N.C. Sonneck et al. Left atrial size quantification using non-contrast-enhanced cardiac computed tomography - association with cardiovascular risk factors and gender-specific distribution in the general population: the Heinz Nixdorf Recall study Acta Radiol 55 2014 917 925
13. K.H. Jöckel, N. Lehmann, and B.R. Jaeger et al. Smoking cessation and subclinical atherosclerosis - results from the Heinz Nixdorf Recall Study Atherosclerosis 203 2009 221 227
14. S. Moebus, A. Stang, and S. Möhlenkamp et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort - results of the Heinz Nixdorf Recall Study Diabetologia 52 2009 81 89
15. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., and R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J. Am. Coll. Cardiol. 15 1990 827 832
16. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. J. Heart Fail. 14 2012 803 869
17. D. Schoenfeld Partial residuals for the proportional hazards regression model Biometrika 69 1982 239 241
18. D. Lin, L.J. Wei, and Z. Ying Checking the Cox model with cumulative sums of martingale-based residuals Biometrika 80 1993 557 572
19. L.E. Chambless, C.P. Cummiskey, and G. Cui Several methods to assess improvement in risk prediction models: extension to survival analysis Stat. Med. 30 2011 22 38
20. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker. From area under the ROC curve to reclassification and beyond Stat. Med. 27 2008 157 172
21. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 62 2013 147 239
22. A.H. Wu Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results Am. Heart J. 152 2006 828 834
23. S.W. Waldo, J. Beede, and S. Isakson et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure J. Am. Coll. Cardiol. 51 2008 1874 1882
24. T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure Heart 91 2005 606 612
25. J.G. Lainchbury, E. Campbell, C.M. Frampton, T.G. Yandle, M.G. Nicholls, and A.M. Richards Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath J. Am. Coll. Cardiol. 42 2003 728 735
26. P. Ray, M. Arthaud, and S. Birolleau et al. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older J. Am. Geriatr. Soc. 53 2005 643 648
27. C. Gorissen, R. Baumgarten, M. De Groot, E. Van Haren, H. Kragten, and M. Leers Analytical and clinical performance of three natriuretic peptide tests in the emergency room Clin. Chem. Lab. Med. 45 2007 678 684